Trial on safety and immunogenicity of Ebola vaccines yields promising results

Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to supplement the available data to develop a safe and effective Ebola vaccine strategies in adults and children alike.

Related Keywords

Guinea , Liberia , United States , United Kingdom , Mali , Sierra Leone , Sharpe Dohme , Yazdan Yazdanpanah , Emily Henderson , Johnson , Saharan African , West Africa , New England Journal , Discovery Industry Focus , Antibodies , Children , Clinical Trial , Efficacy , Immune Response , Medicine , Rain , Placebo , Research , Vaccine , Virus ,